Bharat Serums & Vaccines Ltd pledges Rs 10 lakh to support IVF treatments

The money will be donated to ISAR to allocate it for the treatment of those poor patients who had stopped treatment due to COVID19

Bharat Serums and Vaccines Limited, IVF, Fertility treatments, COVID-19, Sanjiv Navangul, Dr Hrishikesh Pai, Dr Firuza Parikh, Dr Neena Malhotra, Dr Jaideep Malhotra, Indian Society for Assisted Reproduction (ISAR), Dr Prakash Trivedi

Adding to its ongoing efforts to develop an antidote for COVID-19 patients, Bharat Serums and Vaccines Ltd. (BSVL),  announced a corpus of Rs 10 lakhs towards a fund to support IVF treatment for couples who are eligible but poor at the ‘India IVF Summit’ by Integrated Health and Wellbeing (IHW) Council. Sanjiv Navangul, Managing Director and CEO, BSVL added that the company will conduct a multi-stakeholder study to quantify the economic cost of infertility.

“Bharat Serums & Vaccines will lead a multi-stakeholder study to quantify the economic cost of infertility. The key objective of this study will be to gather necessary data and insights to create a framework to fight against this epidemic of infertility in partnership with all stakeholders," said Sanjiv Navangul, Managing Director and CEO, Bharat Serums and Vaccines Ltd. (BSVL). The study will also have qualitative assessment of the impact of infertility in society viz depression, suicide, abuse against women and an overall social stigma. "We will present the findings to the government so that they can note the ground realities and formulate right policies in this direction," he added.


Leading gynaecologists and infertility specialists at the day-long virtual summit, organised on the World IVF Day and supported by Bharat Serums and Vaccines Ltd. (BSVL), concurred that better diagnostics, affordable prices and setting realistic expectations can shred the myth of infertility treatment being the privy to the rich.

Eminent IVF experts Dr Firuza Parikh, Director, Assisted Reproduction and Genetics, Jaslok Hospital and Research Centre, Mumbai, Dr Hrishikesh Pai, Medical Director, Bloom IVF, Mumbai, Dr. Prakash Trivedi, President of Indian Society for Assisted Reproduction (ISAR), Dr. Jaideep Malhotra, Immediate Past President, ISAR, and Director, Rainbow IVF, and Dr Neena Malhotra, Professor, ART Centre, Department of Obstetrics and Gynaecology, All India Institute of Medical sciences, New Delhi as well as policymakers and legal experts attended the summit.

“There is a rise in number of people with infertility as globally, sperm count has gone down, male sexual dysfunction and cases of infections have increased. It is important to set realistic expectations – having IVF may not solve everything, less-costly treatments such IUI with a success rate of 12 per cent can also solve many of the fertility problems. There is a need to bring in better diagnostics, evaluation, and treatment for infertility. Centres should offer higher level of treatment and make it available at an affordable price – ISAR has 3 centres that allows free treatment of people who need it,” said Dr Prakash Trivedi, President of Indian Society for Assisted Reproduction (ISAR).

“There are about 300 million reproductive couples in India and about 10 per cent of them have problem that requires IVF. Doctors need to assess the case to understand what the patient needs and communicate it effectively to the patient. Besides, infertility treatment should be covered by the government like the NHS does in the UK. There are schemes in Madhya Pradesh for people below poverty line – schemes like Ayushman Bharat should provide infertility treatment,” said Dr Hrishikesh Pai, Medical Director, Bloom IVF, Mumbai.